Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds
- 1 March 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 146 (3) , 365-374
- https://doi.org/10.1046/j.1365-2133.2002.04605.x
Abstract
Summary Background Antiseptic agents, particularly slow‐release preparations, are increasingly being used in the management of chronic wounds. One such agent, cadexomer iodine, carries iodine (0·9% weight/weight) immobilized in beads of dextrin and epichlorhydrin and has been demonstrated to be highly effective in promoting healing of exudative wounds. However, there have been no studies directly assessing the potential lack of toxicity of cadexomer iodine on human cutaneous tissues. Objectives To determine if, within a certain concentration range, cadexomer iodine is non‐toxic to human cells and cutaneous tissue and to assess histologically human chronic exudative wounds that are being treated with cadexomer iodine. Methods We examined the effects of varying concentrations of cadexomer iodine on the viability of human fibroblasts in culture (by trypan blue exclusion). The morphology, cellular proliferation capacity (measured by [3H]thymidine uptake), ability to produce α1(I) procollagen chain mRNA, and cell outgrowth from neonatal foreskin explants were also evaluated in human fibroblasts after incubation with various concentrations of cadexomer iodine. Moreover, biopsies of chronic exudative wounds concurrently treated with cadexomer iodine were stained with haematoxylin and eosin or a Gram stain and evaluated microscopically. Results At concentrations of up to 0·45%, cadexomer iodine was found to be non‐toxic to fibroblasts in vitro; there were no changes in viability, morphology, cellular proliferation, ability to produce collagen, and cell outgrowth from explants. In vivo, skin biopsies of chronic exudative wounds being treated with cadexomer iodine demonstrated no evidence of cell necrosis, displayed re‐epithelialization, and revealed bacteria within the cadexomer beads. Conclusions These studies demonstrate that cadexomer iodine has definite non‐toxic concentration ranges for fibroblasts in vitro, which are consistent with a lack of cellular toxicity in human chronic exudative wounds treated with cadexomer iodine. Cadexomer iodine may also have the additional property of trapping microorganisms.Keywords
This publication has 24 references indexed in Scilit:
- Classifications for wound bed preparation and stimulation of chronic woundsWound Repair and Regeneration, 2000
- Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-β 1Journal of Dermatological Science, 1997
- Iodine released from the wound dressing iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharideThe International Journal of Biochemistry & Cell Biology, 1997
- Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.Journal of Clinical Investigation, 1995
- A modified technique of delayed primary closure using a povidone iodine wick: Influence on wound healing in an experimental modelIrish Journal of Medical Science, 1993
- Hypoxia Upregulates the Synthesis of TGF-β1 by Human Dermal FibroblastsJournal of Investigative Dermatology, 1991
- Protein measurement using bicinchoninic acid: elimination of interfering substancesAnalytical Biochemistry, 1989
- Transforming Growth Factor-Beta: Selective Increase in Glycosaminoglycan Synthesis by Cultures of Fibroblasts From Patients With Progressive Systemic SclerosisJournal of Investigative Dermatology, 1987
- A study to assess the effects of a new Betadine cream formulation compared to a standard topical treatment regimen for burnsBurns, 1987
- A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcersBritish Journal of Dermatology, 1983